Gómez-Gil E et al. |
Clarithromycin-induced acute psychoses in peptic ulcer disease. |
1999 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:10192720
|
Lee CK et al. |
Immunization with recombinant Helicobacter pylori urease decreases colonization levels following experimental infection of rhesus monkeys. |
1999 |
Vaccine |
pmid:10195786
|
Bartnof HS |
OIs and cancers. |
1999 |
BETA |
pmid:11367262
|
Gimenez Garcia R et al. |
Fish tank granuloma: response to treatment with clarithromycin. |
1999 |
J Eur Acad Dermatol Venereol |
pmid:10188167
|
Dubé MP et al. |
Successful short-term suppression of clarithromycin-resistant Mycobacterium avium complex bacteremia in AIDS. California Collaborative Treatment Group. |
1999 |
Clin. Infect. Dis. |
pmid:10028084
|
Shirtliff ME et al. |
Oral rifampin plus azithromycin or clarithromycin to treat osteomyelitis in rabbits. |
1999 |
Clin. Orthop. Relat. Res. |
pmid:10078148
|
Ong EL |
Prophylaxis against disseminated Mycobacterium avium complex in AIDS. |
1999 |
J. Infect. |
pmid:10090497
|
Osato MS et al. |
Metronidazole and clarithromycin resistance amongst Helicobacter pylori isolates from a large metropolitan hospital in the United States. |
1999 |
Int. J. Antimicrob. Agents |
pmid:10493611
|
Hirsh DC and Jang SS |
Antimicrobial susceptibility of Nocardia nova isolated from five cats with nocardiosis. |
1999 |
J. Am. Vet. Med. Assoc. |
pmid:10496134
|
Ellenrieder V et al. |
Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication. |
1999 |
Scand. J. Gastroenterol. |
pmid:10499474
|
Landesman KA et al. |
Rhabdomyolysis associated with the combined use of hydroxymethylglutaryl-coenzyme A reductase inhibitors with gemfibrozil and macrolide antibiotics. |
1999 |
Conn Med |
pmid:10500341
|
Unge P |
The OAC and OMC options. |
1999 |
Eur J Gastroenterol Hepatol |
pmid:10503817
|
Feldman M et al. |
Influence of H. pylori infection on meal-stimulated gastric acid secretion and gastroesophageal acid reflux. |
1999 |
Am. J. Physiol. |
pmid:10600812
|
Spiller RC |
Is there any difference in Helicobacter pylori eradication rates in patients with active peptic ulcer, inactive peptic ulcer and functional dyspepsia? |
1999 |
Eur J Gastroenterol Hepatol |
pmid:10503819
|
Sainz R et al. |
[Helicobacter pylori infection. The Spanish consensus report. The Spanish Consensus Conference Group]. |
1999 |
Rev Esp Enferm Dig |
pmid:10601771
|
Kohyama T et al. |
Fourteen-member macrolides inhibit interleukin-8 release by human eosinophils from atopic donors. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10103198
|
GarcÃa-Arata MI et al. |
Mutations in 23S rRNA in Helicobacter pylori conferring resistance to erythromycin do not always confer resistance to clarithromycin. |
1999 |
Antimicrob. Agents Chemother. |
pmid:9925537
|
Bortolotti M et al. |
Effect of intravenous clarithromycin on interdigestive gastroduodenal motility of patients with functional dyspepsia and Helicobacter pylori gastritis. |
1999 |
Dig. Dis. Sci. |
pmid:10630494
|
Fattorini L et al. |
Activities of eighteen antimicrobial regimens against Mycobacterium avium infection in beige mice. |
1999 |
Microb. Drug Resist. |
pmid:10566874
|
Juurlink DN and Ito S |
Comment: clarithromycin-digoxin interaction. |
1999 |
Ann Pharmacother |
pmid:10630847
|
Talley NJ et al. |
Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. |
1999 |
N. Engl. J. Med. |
pmid:10511608
|
Lamouliatte H et al. |
Double vs. single dose of pantoprazole in combination with clarithromycin and amoxycillin for 7 days, in eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10571611
|
Baylor P and Williams K |
Interstitial nephritis, thrombocytopenia, hepatitis, and elevated serum amylase levels in a patient receiving clarithromycin therapy. |
1999 |
Clin. Infect. Dis. |
pmid:10525003
|
Stengel W |
[Sporotrichoid mycobacteriosis caused by Mycobacterium marinum]. |
1999 |
Dtsch. Med. Wochenschr. |
pmid:10572519
|
Madsen LG et al. |
Ménétrier's disease and Helicobacter pylori: normalization of gastrointestinal protein loss after eradication therapy. |
1999 |
Dig. Dis. Sci. |
pmid:10573379
|
Furusyo N et al. |
Rapidly growing primary gastric B-cell lymphoma after eradication of Helicobacter pylori. |
1999 |
Intern. Med. |
pmid:10526942
|
Semret M et al. |
Mycobacterium ulcerans infection (Buruli ulcer): first reported case in a traveler. |
1999 |
Am. J. Trop. Med. Hyg. |
pmid:10586895
|
Chérin P et al. |
Macrophagic myofasciitis: improvement with antibiotic therapy. |
1999 |
J. Rheumatol. |
pmid:10529163
|
Nasu T et al. |
[In vitro antibacterial activity of faropenem, a novel oral penem antibiotic, against enterohemorrhagic Escherichia coli O157 strains]. |
1999 |
Jpn J Antibiot |
pmid:10587879
|
Moola S et al. |
A multicenter study of grepafloxacin and clarithromycin in the treatment of patients with community-acquired pneumonia. |
1999 |
Chest |
pmid:10531162
|
Langan CE et al. |
Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis. |
1999 |
J. Antimicrob. Chemother. |
pmid:10588313
|
Houben MH et al. |
Randomized trial of omeprazole and clarithromycin combined with either metronidazole or amoxycillin in patients with metronidazole-resistant or -susceptible Helicobacter pylori strains. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10383522
|
Tomiyama Y et al. |
[The combination therapy of clarithromycin and sparfloxacin for pulmonary Mycobacterium gordonae infection]. |
1999 |
Kekkaku |
pmid:10386036
|
Katsura Y et al. |
Anti-Helicobacter pylori agents. 3. 2-[(Arylalkyl)guanidino]-4-furylthiazoles. |
1999 |
J. Med. Chem. |
pmid:10425101
|
Marini RP et al. |
Ranitidine bismuth citrate and clarithromycin, alone or in combination, for eradication of Helicobacter mustelae infection in ferrets. |
1999 |
Am. J. Vet. Res. |
pmid:10791942
|
Grimm KJ |
Treatment of Helicobacter pylori infection in functional dyspepsia. |
1999 |
J Fam Pract |
pmid:10428242
|
Gooch WM et al. |
Loracarbef versus clarithromycin in children with acute otitis media with effusion. |
1999 |
Clin Ther |
pmid:10363736
|
Pilotto A et al. |
Efficacy of 7 day lansoprazole-based triple therapy for Helicobacter pylori infection in elderly patients. |
1999 |
J. Gastroenterol. Hepatol. |
pmid:10355512
|
Jacoby EB and Porter KB |
Helicobacter pylori infection and persistent hyperemesis gravidarum. |
1999 |
Am J Perinatol |
pmid:10355915
|
Fost DA et al. |
Inhibition of methylprednisolone elimination in the presence of clarithromycin therapy. |
1999 |
J. Allergy Clin. Immunol. |
pmid:10359882
|
Bhasin DK et al. |
Helicobacter pylori eradication: comparison of three treatment regimens in India. |
1999 |
J. Clin. Gastroenterol. |
pmid:10372934
|
Behrens R et al. |
Dual versus triple therapy of Helicobacter pylori infection: results of a multicentre trial. |
1999 |
Arch. Dis. Child. |
pmid:10373140
|
Masa K et al. |
Effect of clarithromycin and other macrolides on the sulfoxidation and 5-hydroxylation of lansoprazole in dogs. |
1999 |
Biol. Pharm. Bull. |
pmid:10375172
|
Principi N and Esposito S |
Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patients. |
1999 |
Drug Saf |
pmid:9935275
|
Allevi P et al. |
A new convenient transformation of erythromycin A into clarithromycin. |
1999 |
Bioorg. Med. Chem. |
pmid:10658579
|
Kamochi H et al. |
Clarithromycin associated with torsades de pointes. |
1999 |
Jpn. Circ. J. |
pmid:10943628
|
Periti P and Mazzei T |
Clarithromycin: pharmacokinetic and pharmacodynamic interrelationships and dosage regimen. |
1999 |
J Chemother |
pmid:10078776
|
Sunazuka T et al. |
Effects of erythromycin and its derivatives on interleukin-8 release by human bronchial epithelial cell line BEAS-2B cells. |
1999 |
J. Antibiot. |
pmid:10092202
|
Anzueto A et al. |
Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: ciprofloxacin 750 mg b.i.d. versus clarithromycin 500 mg b.i.d. Bronchitis Study Group. |
1998 Sep-Oct |
Clin Ther |
pmid:9829441
|
Miehlke S et al. |
Comparison of omeprazole, metronidazole and clarithromycin with omeprazole/amoxicillin dual-therapy for the cure of Helicobacter pylori infection. |
1998 Nov-Dec |
Digestion |
pmid:9813387
|
Adelglass J et al. |
A multicenter, investigator-blinded, randomized comparison of oral levofloxacin and oral clarithromycin in the treatment of acute bacterial sinusitis. |
1998 Nov-Dec |
Pharmacotherapy |
pmid:9855324
|
Tohnai A et al. |
Clarithromycin suppresses proliferation of rat nasal epithelium exposed to endotoxin. |
1998 Nov-Dec |
Am J Rhinol |
pmid:9883303
|
Mermelstein HT |
Clarithromycin-induced delirium in a general hospital. |
1998 Nov-Dec |
Psychosomatics |
pmid:9819955
|
Oberg KC |
Delayed elevation of international normalized ratio with concurrent clarithromycin and warfarin therapy. |
1998 Mar-Apr |
Pharmacotherapy |
pmid:9545160
|
Vakil N |
Treatment of H. pylori infection: the reality. |
1998 Mar-Apr |
Yale J Biol Med |
pmid:10378357
|
Venuta A et al. |
Azithromycin compared with clarithromycin for the treatment of streptococcal pharyngitis in children. |
1998 Jun-Jul |
J. Int. Med. Res. |
pmid:9718470
|
Fernández Bermejo M and GarcÃa Grávalos R |
[Ebrotidine in the eradicating treatment of H. pylori]. |
1998 Jun-Jul |
Gastroenterol Hepatol |
pmid:9711019
|
Shafran SD |
Prevention and treatment of disseminated Mycobacterium avium complex infection in human immunodeficiency virus-infected individuals. |
1998 Jul-Sep |
Int. J. Infect. Dis. |
pmid:9831675
|
Langan C et al. |
Short-course cefuroxime axetil therapy in the treatment of acute exacerbations of chronic bronchitis. |
1998 Jul-Aug |
Int. J. Clin. Pract. |
pmid:9796558
|
Habu Y et al. |
Triple therapy with omeprazole, amoxicillin and clarithromycin is effective against Helicobacter pylori infection in gastric ulcer patients as well as in duodenal ulcer patients. Results of a randomized controlled trial in Japan. |
1998 Jul-Aug |
Digestion |
pmid:9693202
|
Mikamo H et al. |
Effects of long-term/low-dose clarithromycin on neutrophil count and interleukin-8 level in pyometra. |
1998 Jan-Feb |
Chemotherapy |
pmid:9444409
|
Ziering W and McElvaine P |
Randomized comparison of once-daily ceftibuten and twice-daily clarithromycin in the treatment of acute exacerbation of chronic bronchitis. |
1998 Jan-Feb |
Infection |
pmid:9505188
|
Fennerty MB et al. |
A comparison of 10 and 14 days of lansoprazole triple therapy for eradication of Helicobacter pylori. |
1998 Aug 10-24 |
Arch. Intern. Med. |
pmid:9701099
|
Dehesa M et al. |
[Comparison of 2 schedules based on pantoprazole for eradication of Helicobacter pylori in patients with active duodenal ulcer]. |
1998 Apr-Jun |
Rev Gastroenterol Mex |
pmid:10068730
|
Al-Sibai MB et al. |
Ocular penetration of oral clarithromycin in humans. |
1998 |
J Ocul Pharmacol Ther |
pmid:9867340
|
Abouesh A and Hobbs WR |
Clarithromycin-induced mania. |
1998 |
Am J Psychiatry |
pmid:9812131
|
Pipkin GA et al. |
Review article: one-week clarithromycin triple therapy regimens for eradication of Helicobacter pylori. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9768524
|
Gikas A et al. |
In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9756789
|
Debets-Ossenkopp YJ et al. |
Explaining the bias in the 23S rRNA gene mutations associated with clarithromycin resistance in clinical isolates of Helicobacter pylori. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9756790
|
Hogan PA and Sheehan DJ |
Macrolide susceptibility and beta-lactamase production among haemophilus influenzae isolates in the United States, 1996-1997. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9835536
|
Lygren I et al. |
[Treatment of Helicobacter pylori infection]. |
1998 |
Tidsskr. Nor. Laegeforen. |
pmid:9889634
|
Einarson A et al. |
A prospective controlled multicentre study of clarithromycin in pregnancy. |
1998 |
Am J Perinatol |
pmid:9890248
|
Abe M et al. |
A case of diffuse panbronchiolitis effectively treated with low-dose macrolide antibiotics and leukotriene D4/E4 receptor antagonist. |
1998 |
Respir Med |
pmid:9893782
|
Pozzato P et al. |
Ranitidine bismuth citrate plus clarithromycin 7-day regimen is effective in eradicating Helicobacter pylori in patients with duodenal ulcer. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9663724
|
Griffith DE |
Mycobacteria as pathogens of respiratory infection. |
1998 |
Infect. Dis. Clin. North Am. |
pmid:9779380
|
Berry V et al. |
Bacteriological efficacies of three macrolides compared with those of amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9835514
|
Butt AA |
Cervical adenitis due to Mycobacterium fortuitum in patients with acquired immunodeficiency syndrome. |
1998 |
Am. J. Med. Sci. |
pmid:9427575
|
Trevisani L et al. |
A four-day low dose triple therapy regimen for the treatment of Helicobacter pylori infection. |
1998 |
Am. J. Gastroenterol. |
pmid:9517646
|
O'Connor HJ et al. |
Lansoprazole triple therapy for Helicobacter pylori--is 5 days enough? |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9570262
|
Scott BB |
Bismuth-containing single-antibiotic 1-week triple therapy for Helicobacter pylori eradication. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9570263
|
Jarboe E et al. |
Evaluation of a disk diffusion method for determining susceptibility of Mycobacterium avium complex to clarithromycin. |
1998 |
Diagn. Microbiol. Infect. Dis. |
pmid:9572027
|
Treiber G et al. |
Amoxicillin/metronidazole/omeprazole/clarithromycin: a new, short quadruple therapy for Helicobacter pylori eradication. |
1998 |
Helicobacter |
pmid:9546119
|
Murata H et al. |
Evaluation of the PyloriTek test for detection of Helicobacter pylori infection in cases with and without eradication therapy. |
1998 |
Am. J. Gastroenterol. |
pmid:9820380
|
Laine L et al. |
Twice-daily, 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in duodenal ulcer disease: results of three multicenter, double-blind, United States trials. |
1998 |
Am. J. Gastroenterol. |
pmid:9820381
|
Yano S et al. |
[Significance of therapeutic efficacy of clarithromycin in a model for human lung cancer metastasis and a mouse tumor system]. |
1998 |
Jpn J Antibiot |
pmid:9597491
|
Sasa K et al. |
[Antineoplastic therapeutic effect of clarithromycin in rats]. |
1998 |
Jpn J Antibiot |
pmid:9597492
|
Miyamoto N et al. |
[Test to set dosages for long-term administration of clarithromycin to treat chronic paranasal sinusitis]. |
1998 |
Jpn J Antibiot |
pmid:9597498
|
Fujita K et al. |
[Neutrophil count and IL-8 level of nasal secretion of patients with chronic paranasal sinusitis and the effects of macrolide antibiotics]. |
1998 |
Jpn J Antibiot |
pmid:9597505
|
Scheen AJ |
[Drug clinics. The drug of the month. Ranitidine bismuth citrate (Pylorid)]. |
1998 |
Rev Med Liege |
pmid:9555183
|
Cheng KL et al. |
Effect of grapefruit juice on clarithromycin pharmacokinetics. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9559810
|
Goujard C et al. |
Clarithromycin-resistant Mycobacterium avium strain in a clarithromycin-naive AIDS patient. |
1998 |
Clin. Infect. Dis. |
pmid:9455532
|
Williamson R et al. |
New options in Helicobacter pylori eradication: efficacy, resistance and synergy. |
1998 |
Scand. J. Gastroenterol. Suppl. |
pmid:9515751
|
Carr RA et al. |
Steady-state pharmacokinetics and electrocardiographic pharmacodynamics of clarithromycin and loratadine after individual or concomitant administration. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9593146
|
Lacy MK et al. |
Comparison of bactericidal activity after multidose administration of clarithromycin, azithromycin, and ceruroxime axetil against Streptococcus pneumoniae. |
1998 |
Int. J. Antimicrob. Agents |
pmid:9916901
|
Sörberg M et al. |
Risk of development of in vitro resistance to amoxicillin, clarithromycin, and metronidazole in Helicobacter pylori. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9593154
|
Fera MT et al. |
Bactericidal activity of lansoprazole and three macrolides against Helicobacter pylori strains tested by the time-kill kinetic method. |
1998 |
Int. J. Antimicrob. Agents |
pmid:9916902
|
Ellenrieder V et al. |
Influence of clarithromycin dosage on pantoprazole combined triple therapy for eradication of Helicobacter pylori. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9701524
|
Burman WJ et al. |
AIDS-related Mycobacterium kansasii infection with initial resistance to clarithromycin. |
1998 |
Diagn. Microbiol. Infect. Dis. |
pmid:9635911
|
Nordt SP et al. |
Clarithromycin induced digoxin toxicity. |
1998 |
J Accid Emerg Med |
pmid:9639187
|
Gray VS |
Syncopal episodes associated with cisapride and concurrent drugs. |
1998 |
Ann Pharmacother |
pmid:9640482
|